Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Vitamin D non-sufficiency is prevalent in children with chronic liver disease in a tropical country.

Lee WS, Jalaludin MY, Wong SY, Ong SY, Foo HW, Ng RT.

Pediatr Neonatol. 2018 Apr 5. pii: S1875-9572(17)30332-7. doi: 10.1016/j.pedneo.2018.03.011. [Epub ahead of print]

2.

[NISCH syndrome, a rare cause of neonatal cholestasis: A case report].

Szepetowski S, Lacoste C, Mallet S, Roquelaure B, Badens C, Fabre A.

Arch Pediatr. 2017 Dec;24(12):1228-1234. doi: 10.1016/j.arcped.2017.09.016. Epub 2017 Nov 13. French.

PMID:
29146216
3.

Vitamin A deficiency in chronic cholestatic liver disease: Is vitamin A therapy beneficial?

Freund C, Gotthardt DN.

Liver Int. 2017 Dec;37(12):1752-1758. doi: 10.1111/liv.13433. Epub 2017 Jul 29. Review.

PMID:
28371374
4.

[Overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis: First case in a context of autoimmunity and hypovitaminosis D].

Benabderrahmane H, Roula D.

Presse Med. 2017 Apr;46(4):457-459. doi: 10.1016/j.lpm.2017.01.009. Epub 2017 Mar 15. French. No abstract available.

PMID:
28314443
5.

Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective.

Marchioni Beery RM, Vaziri H, Forouhar F.

J Clin Transl Hepatol. 2014 Dec;2(4):266-84. doi: 10.14218/JCTH.2014.00024. Epub 2014 Dec 15. Review. Erratum in: J Clin Transl Hepatol. 2015 Jun 28;3(2):162.

6.
7.

Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.

Chen Y, Guldiken N, Spurny M, Mohammed HH, Haybaeck J, Pollheimer MJ, Fickert P, Gassler N, Jeon MK, Trautwein C, Strnad P.

J Pathol. 2015 Nov;237(3):343-54. doi: 10.1002/path.4580. Epub 2015 Aug 3.

PMID:
26108453
8.

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology.

Am J Gastroenterol. 2015 May;110(5):646-59; quiz 660. doi: 10.1038/ajg.2015.112. Epub 2015 Apr 14.

PMID:
25869391
9.

1,25-(OH)₂-vitamin D₃ prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model.

Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, Makeschin MC, Mayr D, Rust C, Trauner M, Denk GU.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):227-33. doi: 10.1016/j.bbrc.2015.02.074. Epub 2015 Feb 21.

PMID:
25712522
10.

Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis.

Liaskou E, Jeffery LE, Trivedi PJ, Reynolds GM, Suresh S, Bruns T, Adams DH, Sansom DM, Hirschfield GM.

Gastroenterology. 2014 Jul;147(1):221-232.e7. doi: 10.1053/j.gastro.2014.04.003. Epub 2014 Apr 12.

11.

Cholestatic liver disease.

Gossard AA, Talwalkar JA.

Med Clin North Am. 2014 Jan;98(1):73-85. doi: 10.1016/j.mcna.2013.09.002. Epub 2013 Oct 20. Review.

PMID:
24266915
12.

Retinal structure in vitamin A deficiency as explored with multimodal imaging.

Aleman TS, Garrity ST, Brucker AJ.

Doc Ophthalmol. 2013 Dec;127(3):239-43. doi: 10.1007/s10633-013-9403-0. Epub 2013 Jul 31.

PMID:
23900584
13.

Vitamin D in autoimmune liver disease.

Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):535-45. doi: 10.1016/j.clinre.2013.05.016. Epub 2013 Jul 8. Review.

PMID:
23845396
14.

Care of the cholestatic patient.

Gossard AA.

Clin Liver Dis. 2013 May;17(2):331-44. doi: 10.1016/j.cld.2012.11.005. Epub 2012 Dec 20. Review.

PMID:
23540506
15.
16.

Hepatobiliary complications of inflammatory bowel disease.

Lichtenstein DR.

Curr Gastroenterol Rep. 2011 Oct;13(5):495-505. doi: 10.1007/s11894-011-0213-9. Review.

PMID:
21773706
17.

Improvement in S-cone-mediated visual fields and rod function after correction of vitamin A deficiency.

Hayashi T, Gekka T, Nakano T, Tsuneoka H.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):657-60. doi: 10.5301/EJO.2011.6337.

PMID:
21319138
18.

Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis.

Liaskos C, Norman GL, Moulas A, Garagounis A, Goulis I, Rigopoulou EI, Dalekos GN.

Clin Chim Acta. 2010 Mar;411(5-6):411-5. doi: 10.1016/j.cca.2009.12.012. Epub 2009 Dec 16.

PMID:
20026019
19.

Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.

Baghdasaryan A, Fickert P, Fuchsbichler A, Silbert D, Gumhold J, Hörl G, Langner C, Moustafa T, Halilbasic E, Claudel T, Trauner M.

Liver Int. 2008 Aug;28(7):948-58. doi: 10.1111/j.1478-3231.2008.01758.x. Epub 2008 Apr 11.

PMID:
18410282
20.

Lipids and lipid-activated vitamins in chronic cholestatic diseases.

Kowdley KV.

Clin Liver Dis. 1998 May;2(2):373-89, x. Review.

PMID:
15560038

Supplemental Content

Loading ...
Support Center